RKSG Among Growth ETFs
End-of-day Nov 13, 2026 · 92 Growth ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | 0.0% | +2.3% | −1.0% | −0.3% | — | — | — | — | +14.2% |
| Peer average | −0.8% | +2.8% | −5.6% | −7.0% | +3.0% | +3.4% | +70.7% | +45.8% | — |
| S&P 500 · VOO | −0.4% | +2.6% | −2.3% | −2.1% | +11.5% | +11.6% | +79.3% | +72.7% | — |
$88 of every $1,000 in RKSG is Apple
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | AAPLApple | Technology | 8.79% | $878.82 | 710 | $252K |
| 2 | NVDANvidia | Technology | 7.88% | $788.32 | 1,360 | $226K |
| 3 | MSFTMicrosoft | Technology | 5.20% | $519.89 | 285 | $149K |
| 4 | GOOGLAlphabet | Communication Services | 5.05% | $505.29 | 485 | $145K |
| 5 | LLYEli Lilly | Healthcare | 4.23% | $422.63 | 85 | $121K |
| 6 | AMZNAmazon | Consumer Cyclical | 3.26% | $326.48 | 350 | $94K |
| 7 | AVGOBroadcom | Technology | 2.22% | $222.40 | 175 | $64K |
| 8 | METAMETA Platforms | Communication Services | 2.18% | $217.51 | 100 | $62K |
| 9 | JNJJohnson & Johnson | Healthcare | 2.03% | $202.72 | 205 | $58K |
| 10 | MRKMerck | Healthcare | 1.92% | $192.20 | 375 | $55K |
| 11 | ABBVAbbVie | Healthcare | 1.85% | $184.86 | 180 | $53K |
| 12 | KOCoca-Cola /The | Consumer Defensive | 1.58% | $158.03 | 465 | $45K |
| 13 | LMTLockheed Martin | Industrials | 1.58% | $158.02 | 75 | $45K |
| 14 | REGNRegeneron Pharmaceuticals | Healthcare | 1.49% | $149.29 | 45 | $43K |
| 15 | ALLAllstate /The | Financial Services | 1.44% | $144.18 | 155 | $41K |
Not enough history yet: RKSG needs a year of prices.
RKSG does not pay a distribution.
of the $547B in 113 Growth ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | AAPL | Apple | 8.79% |
| 2 | NVDA | Nvidia | 7.88% |
| 3 | MSFT | Microsoft | 5.20% |
| 4 | GOOGL | Alphabet | 5.05% |
| 5 | LLY | Eli Lilly & | 4.23% |
| 6 | AMZN | Amazon | 3.26% |
| 7 | AVGO | Broadcom | 2.22% |
| 8 | META | META Platforms | 2.18% |
| 9 | JNJ | Johnson & Johnson | 2.03% |
| 10 | MRK | Merck & | 1.92% |
Estimated yearly cost excludes trading costs and assumes constant assets.
No payouts on record: […]